ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $8.3M invested in Enlivex Therapeutics in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

22% less funds holding

Funds holding: 9 → 7 (-2)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.39M
2
+$104K
3
+$86K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.82K

Top Sellers

1
-$1.09M
2
-$518K
3
-$185K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.39M
2
$2.16M
3
$547K
4
$104K
5
$86K
6
$6K
7
–
8
–